US2956062A
(en)
|
1959-02-26 |
1960-10-11 |
Robins Co Inc A H |
Esters of amino alcohols
|
US3175299A
(en)
*
|
1961-08-02 |
1965-03-30 |
American Sugar |
Method of drying sugar crystals with acoustic energy and a gas
|
US3994974A
(en)
|
1972-02-05 |
1976-11-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
α-Aminomethylbenzyl alcohol derivatives
|
SE378109B
(zh)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
US4187301A
(en)
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
US4335121A
(en)
|
1980-02-15 |
1982-06-15 |
Glaxo Group Limited |
Androstane carbothioates
|
CY1359A
(en)
|
1981-02-02 |
1987-08-07 |
Schering Corp |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
DE3268533D1
(en)
*
|
1981-07-24 |
1986-02-27 |
Fisons Plc |
Inhalation drugs, methods for their production and pharmaceutical formulations containing them
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
GB8432063D0
(en)
|
1984-12-19 |
1985-01-30 |
Riker Laboratories Inc |
Physically modified steroids
|
US5707634A
(en)
|
1988-10-05 |
1998-01-13 |
Pharmacia & Upjohn Company |
Finely divided solid crystalline powders via precipitation into an anti-solvent
|
GB8903593D0
(en)
|
1989-02-16 |
1989-04-05 |
Pafra Ltd |
Storage of materials
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
JP3042866B2
(ja)
|
1989-09-08 |
2000-05-22 |
グラクソ・グループ・リミテッド |
呼吸疾患治療薬
|
US5610163A
(en)
|
1989-09-16 |
1997-03-11 |
Boehringer Ingelheim Gmbh |
Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
SG45171A1
(en)
|
1990-03-21 |
1998-01-16 |
Boehringer Ingelheim Int |
Atomising devices and methods
|
PL165803B1
(pl)
|
1990-09-10 |
1995-02-28 |
Schering Corp |
Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL
|
DE4108393A1
(de)
|
1991-03-15 |
1992-09-17 |
Boehringer Ingelheim Kg |
Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
|
SE9101090D0
(sv)
*
|
1991-04-11 |
1991-04-11 |
Astra Ab |
Process for conditioning of water-soluble substances
|
US5874063A
(en)
|
1991-04-11 |
1999-02-23 |
Astra Aktiebolag |
Pharmaceutical formulation
|
SE9302777D0
(sv)
|
1993-08-27 |
1993-08-27 |
Astra Ab |
Process for conditioning substances
|
AU659645B2
(en)
|
1991-06-26 |
1995-05-25 |
Inhale Therapeutic Systems |
Storage of materials
|
CA2356145A1
(en)
|
1991-12-18 |
1993-06-24 |
Aktiebolaget Astra |
New combination of formoterol and budesonide
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US5849263A
(en)
|
1993-03-30 |
1998-12-15 |
Charlotte-Mecklenburg Hospital Authority |
Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
|
GB9313642D0
(en)
|
1993-07-01 |
1993-08-18 |
Glaxo Group Ltd |
Method and apparatus for the formation of particles
|
DE69432224T2
(de)
|
1993-12-02 |
2003-12-04 |
Abbott Lab |
Aerosole als darreichungsform mit cfc-freiem treibmittel
|
SE9404080L
(sv)
|
1993-12-28 |
1995-06-29 |
Ciba Geigy Ag |
Förfarande för framställning av en optiskt ren enantiomer av formoterol
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
EP0742888B1
(en)
|
1994-02-09 |
1998-04-22 |
Kinerton Limited |
Process for drying a material from solution
|
GB9413202D0
(en)
|
1994-06-30 |
1994-08-24 |
Univ Bradford |
Method and apparatus for the formation of particles
|
DE4440337A1
(de)
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
CZ288146B6
(en)
|
1994-12-22 |
2001-05-16 |
Astra Ab |
Pharmaceutical aerosol preparation, process of its preparation and use
|
US5612053A
(en)
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
DE69634246T2
(de)
|
1995-04-14 |
2006-01-12 |
Nektar Therapeutics, San Carlos |
Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit
|
US6258341B1
(en)
|
1995-04-14 |
2001-07-10 |
Inhale Therapeutic Systems, Inc. |
Stable glassy state powder formulations
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
DE19614421C2
(de)
|
1996-04-12 |
1999-12-16 |
Biovision Gmbh |
Verfahren zur Herstellung eines biodegradierbaren Knochenersatz- und Implantatwerkstoffes und biodegradierbarer Knochenersatz- und Implantatwerkstoff
|
GB9610821D0
(en)
|
1996-05-23 |
1996-07-31 |
Glaxo Wellcome Inc |
Metering apparatus
|
GB9612297D0
(en)
|
1996-06-11 |
1996-08-14 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
US6054488A
(en)
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
US5886200A
(en)
|
1996-07-01 |
1999-03-23 |
Schering Corporation |
Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
|
US6068832A
(en)
|
1996-08-29 |
2000-05-30 |
Schering Corporation |
Chlorofluorocarbon-free mometasone furoate aerosol formulations
|
US6040344A
(en)
|
1996-11-11 |
2000-03-21 |
Sepracor Inc. |
Formoterol process
|
SE9700135D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
DK1393721T3
(da)
|
1997-03-20 |
2009-03-30 |
Schering Corp |
Doseringsform af pulveragglomerater
|
US6129905A
(en)
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
US6010935A
(en)
|
1997-08-21 |
2000-01-04 |
Micron Technology, Inc. |
Self aligned contacts
|
SE9703407D0
(sv)
|
1997-09-19 |
1997-09-19 |
Astra Ab |
New use
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
EP1019023B1
(en)
|
1997-09-29 |
2003-05-07 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in nebulizers
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
GB9808470D0
(en)
†
|
1998-04-22 |
1998-06-17 |
Smithkline Beecham Plc |
Novel process and apparatus
|
US6260549B1
(en)
|
1998-06-18 |
2001-07-17 |
Clavius Devices, Inc. |
Breath-activated metered-dose inhaler
|
US6451285B2
(en)
|
1998-06-19 |
2002-09-17 |
Baker Norton Pharmaceuticals, Inc. |
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
|
US6475467B1
(en)
|
1998-08-04 |
2002-11-05 |
Jago Research Ag |
Medicinal aerosol formulations
|
PT1283036E
(pt)
|
1998-11-13 |
2008-03-06 |
Jagotec Ag |
Inalador de pó seco de dose múltipla com um reservatório de pó
|
GB9912639D0
(en)
|
1999-05-28 |
1999-07-28 |
Britannia Pharmaceuticals Ltd |
Improvements in and relating to treatment of respiratory conditions
|
GB9826284D0
(en)
*
|
1998-12-01 |
1999-01-20 |
Rhone Poulence Rorer Limited |
Process
|
CA2356637C
(en)
|
1998-12-22 |
2011-09-13 |
The University Of North Carolina At Chapel Hill |
Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
|
GB9902689D0
(en)
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
GB9903759D0
(en)
|
1999-02-18 |
1999-04-14 |
Novartis Ag |
Organic compounds
|
GB9904919D0
(en)
|
1999-03-03 |
1999-04-28 |
Novartis Ag |
Organic compounds
|
WO2000053157A1
(en)
|
1999-03-05 |
2000-09-14 |
Chiesi Farmaceutici S.P.A. |
Improved powdery pharmaceutical compositions for inhalation
|
SE9900833D0
(sv)
|
1999-03-09 |
1999-03-09 |
Astra Ab |
Novel combination
|
DE19921693A1
(de)
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
JP2002541183A
(ja)
|
1999-04-14 |
2002-12-03 |
グラクソ グループ リミテッド |
医薬用エアゾール製剤
|
US20100197719A1
(en)
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US6255320B1
(en)
*
|
1999-06-01 |
2001-07-03 |
Pfizer Inc. |
Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
|
CA2375601C
(en)
*
|
1999-06-03 |
2008-07-29 |
Eisai Co., Ltd. |
Carbapenem compound crystals and injection preparations
|
MXPA01013168A
(es)
*
|
1999-06-30 |
2002-07-30 |
Inhale Therapeutic Syst |
Proceso de secado por rocio para preparar polvos secos.
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
PT102343B
(pt)
|
1999-08-02 |
2003-11-28 |
Hovione Farmaciencia Sa |
Processo para a preparacao de furoato mometasona
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
PT1666028E
(pt)
|
1999-10-29 |
2010-06-15 |
Novartis Ag |
Composições de pós anidros com melhor dispersividade
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
GB0008660D0
(en)
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
DK1280520T4
(en)
|
2000-05-10 |
2018-06-25 |
Novartis Ag |
Phospholipid based powders for drug delivery
|
US20060257324A1
(en)
|
2000-05-22 |
2006-11-16 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical solution formulations for pressurised metered dose inhalers
|
US20040081627A1
(en)
|
2000-10-09 |
2004-04-29 |
Jinks Phillip A |
Medicinal aerosol formulations
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
EP2298279B1
(en)
|
2000-11-30 |
2018-11-14 |
Vectura Limited |
Pharmaceutical compositions for inhalation
|
GB0030074D0
(en)
*
|
2000-12-08 |
2001-01-24 |
Univ London Pharmacy |
Particulate inhalation carrier
|
US20020141946A1
(en)
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
ITMI20010428A1
(it)
|
2001-03-02 |
2002-09-02 |
Chemo Breath S A |
Composizioni ad uso inalatorio a base di formoterolo
|
IL157580A0
(en)
|
2001-03-20 |
2004-03-28 |
Glaxo Group Ltd |
Inhalation drug combination
|
NZ528640A
(en)
|
2001-03-30 |
2004-06-25 |
Jagotec Ag |
Medical aerosol formulations
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
US6848197B2
(en)
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
DE10120484A1
(de)
*
|
2001-04-25 |
2002-10-31 |
Degussa |
Verfahren und Vorrichtung zur thermischen Behandlung von pulverförmigen Stoffen
|
DE10130371A1
(de)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
US20030018019A1
(en)
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
AR036358A1
(es)
|
2001-08-28 |
2004-09-01 |
Schering Corp |
Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
|
DE10202940A1
(de)
|
2002-01-24 |
2003-07-31 |
Sofotec Gmbh & Co Kg |
Patrone für einen Pulverinhalator
|
WO2003075854A2
(en)
|
2002-03-07 |
2003-09-18 |
Avalon Pharmaceuticals |
Cancer-linked gene as target for chemotherapy
|
DE10214264A1
(de)
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen eines Anhydrats
|
GB0207906D0
(en)
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and mometasone aerosol formulations
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
MXPA04012410A
(es)
|
2002-06-12 |
2005-10-19 |
Epigenesis Pharmaceuticals Inc |
Composiciones, formulaciones y equipo para el tratamiento de enfermedades pulmonares y respiratorias con deshidroepiandrosteronas, esteroides y agentes antimuscarinicos.
|
DE10237739A1
(de)
|
2002-08-17 |
2004-02-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
|
US7244742B2
(en)
|
2002-08-17 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
|
US6942821B2
(en)
|
2002-10-15 |
2005-09-13 |
Cryovac, Inc. |
Process for triggering, storing, and distributing an oxygen scavenger, and a stored oxygen scavenger
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
DE10323966A1
(de)
|
2003-05-27 |
2004-12-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
|
JP2007500234A
(ja)
|
2003-05-28 |
2007-01-11 |
ネクター セラピューティクス |
水に不溶な活性剤を含む医薬的成形
|
US7238664B2
(en)
|
2003-06-16 |
2007-07-03 |
Altana Pharma Ag |
Composition comprising a pulmonary surfactant and a PDE5 inhibitor for the treatment of lung diseases
|
SE527190C2
(sv)
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
|
EP1651221B1
(en)
|
2003-07-28 |
2009-01-14 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising betamimetics and an anticholinergic agent
|
WO2005014044A1
(en)
|
2003-07-29 |
2005-02-17 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising betamimetics and an anticholinergic
|
BRPI0413054A
(pt)
|
2003-07-29 |
2006-10-17 |
Boehringer Ingelheim Int |
combinação de um anticolinérgico e um esteróide e seu uso no tratamento de distúrbios respiratórios por inalação
|
ATE526967T1
(de)
|
2003-07-31 |
2011-10-15 |
Boehringer Ingelheim Int |
Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum
|
US9308199B2
(en)
|
2004-04-29 |
2016-04-12 |
Honeywell International Inc. |
Medicament formulations
|
SE0303270L
(sv)
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
WO2005074900A2
(en)
|
2004-02-06 |
2005-08-18 |
Meda Pharma Gmbh & Co. Kg |
NOVEL COMBINATION OF ANTICHOLINERGIC AND β MIMETICS FOR THE TREATMENT OF RESPIRATORY DISEASES
|
WO2005074918A1
(en)
|
2004-02-06 |
2005-08-18 |
Benzstrasse 1 D-61352 Bad Homburd |
The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
|
WO2005077339A1
(en)
|
2004-02-10 |
2005-08-25 |
E.I. Dupont De Nemours And Company |
Process for preparing stable sol of pharmaceutical ingredients and hydrofluorocarbon comprising milling the said sol, then transfert it into a canister
|
GB0409703D0
(en)
*
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
AU2005247410A1
(en)
*
|
2004-05-20 |
2005-12-08 |
Discovery Laboratories, Inc. |
Methods , systems and devices for noninvasive pulmonary delivery
|
PT1765288E
(pt)
|
2004-06-18 |
2013-01-29 |
Novartis Ag |
Métodos de tratamento de infeções endobrônquicas
|
GB0426301D0
(en)
|
2004-11-30 |
2004-12-29 |
Vectura Ltd |
Pharmaceutical formulations
|
EP1861361A1
(en)
|
2005-03-24 |
2007-12-05 |
Sosei R&D Ltd. |
Glycopyrronium salts and their therapeutic use
|
WO2006105401A2
(en)
|
2005-03-30 |
2006-10-05 |
Schering Corporation |
Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
|
JP2008538758A
(ja)
|
2005-04-23 |
2008-11-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物
|
GB0523653D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
EP1893203A2
(en)
|
2005-05-31 |
2008-03-05 |
Boehringer Ingelheim International GmbH |
Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
|
WO2007009164A1
(en)
|
2005-07-15 |
2007-01-25 |
Eiffel Technologies Limited |
Method of particle formation
|
CN100560598C
(zh)
|
2005-07-26 |
2009-11-18 |
上海奥锐特国际贸易有限公司 |
氟替卡松丙酸酯的合成方法
|
GB0523655D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
GB0523656D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
GB0523654D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
EP1971369B1
(en)
|
2005-12-21 |
2009-08-19 |
MEDA Pharma GmbH & Co. KG |
Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
WO2007095041A2
(en)
|
2006-02-09 |
2007-08-23 |
Schering Corporation |
Pharmaceutical formulations
|
JP2009537585A
(ja)
|
2006-05-24 |
2009-10-29 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器疾患の治療のための新規医薬組成物
|
GB0613161D0
(en)
|
2006-06-30 |
2006-08-09 |
Novartis Ag |
Organic Compounds
|
GB0614621D0
(en)
|
2006-07-24 |
2006-08-30 |
3M Innovative Properties Co |
Metered dose dispensers
|
EP1894568A1
(en)
|
2006-08-31 |
2008-03-05 |
Novartis AG |
Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
|
KR20090121338A
(ko)
|
2007-02-19 |
2009-11-25 |
씨아이피엘에이 엘티디. |
두 개 이상의 기관지확장제 또는 기관지확장제와 코르티코스테로이드의 약제학적 조합
|
EP2036572A1
(en)
|
2007-09-04 |
2009-03-18 |
Novo Nordisk A/S |
Process for drying a protein, a protein particle and a pharmaceutical composition comprising the protein particle
|
GB0801876D0
(en)
|
2008-02-01 |
2008-03-12 |
Vectura Group Plc |
Suspension formulations
|
FR2940162B1
(fr)
|
2008-12-22 |
2011-02-25 |
Boehm & Cie Ets |
Outil de frappe multi-usages a mecanisme absorbant l'energie transmise au moyen de prehension
|
WO2010097188A1
(en)
|
2009-02-25 |
2010-09-02 |
Chiesi Farmaceutici S.P.A. |
Inhalation particles comprising a salt of carmoterol and a corticosteroid
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
CA2763939A1
(en)
|
2009-05-29 |
2010-12-02 |
Pearl Therapeutics, Inc. |
Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems
|
US20150093440A1
(en)
*
|
2010-10-15 |
2015-04-02 |
Glaxo Group Limited |
Aggregate nanoparticulate medicament formulations, manufacture and use thereof
|
CA2827045A1
(en)
|
2011-02-17 |
2012-08-23 |
Cipla Limited |
Compositions of glycopyrrolate and a beta2-agonist
|
JO3510B1
(ar)
*
|
2011-03-04 |
2020-07-05 |
Heptares Therapeutics Ltd |
استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
|
EP2709447A4
(en)
|
2011-05-17 |
2014-10-22 |
Pearl Therapeutics Inc |
COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY ADMINISTRATION OF AT LEAST TWO ACTIVE AGENTS
|
US20120325942A1
(en)
|
2011-06-27 |
2012-12-27 |
General Electric Company |
Jet milling of boron powder using inert gases to meet purity requirements
|
KR102391332B1
(ko)
|
2013-03-15 |
2022-04-26 |
펄 테라퓨틱스 인코포레이티드 |
미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
|